Men with localized prostate cancer were enrolled in a trial that randomized men to either conventionally fractionated intensity modulated radiation therapy ( CIMRT , @ Gy in @-Gy fractions ) or to dose-escalated hypofractionated IMRT ( HIMRT , @ Gy in @-Gy fractions ) .